Live
Merck & Co.Merck & Co. Inc. stock (US58933Y1055): Earnings beat and pipeline update drive investor interest - AD HOC NEWSMettler ToledoMettler Toledo (MTD) Margin Slippage Tests Bullish Earnings Growth Narratives - simplywall.stLabCorpLabcorp stock (US50540R4092): Diagnostic and drug development leader in focus for US investors - AD HOC NEWSCellFerroptosis inhibition enhances liver and lung graft functionCell<em>Streptomyces</em> enrichment in roots during drought is uncoupled from plant benefit and is driven by host suppression of iron uptake and immunityCellAI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathologyCellMultimodal clocks of human agingCellThe rise of polyploids during environmental upheavalMerck KGaAMerck KGaA stock (DE0006599905): Pharma and tech group eyes growth in US markets - AD HOC NEWSCharles RiverCharles River Laboratories stock (US1591881009): Shares dip after recent run-up as analysts eye upsi - AD HOC NEWSEurofinsEurofins Scientific SE stock (FR0014000MR3): Lab testing group eyes growth amid regulatory shifts an - AD HOC NEWSEndpoints NewsBiotech’s new company model; The super poop behind a startup launch; and more
Endpoints News Mar 25, 2026

Gilgamesh's psychedelics pipeline gets $60M backing after AbbVie deal

Gilgamesh's psychedelics pipeline gets $60M backing after AbbVie deal

Original
Body unavailable. Use the original source.